Carcinoid, Neuroendocrine tumour (NET)
Results
Phase 3
This trial looked at a drug called telotristat etiprate for people who had symptoms of carcinoid syndrome that were not controlled with other drugs.
This trial was open between 2013 and 2015 for people to join. The results were published in 2018.
Recruitment start: 1 January 2013
Recruitment end: 28 February 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Martyn Caplin
Experimental Cancer Medicine Centre (ECMC)
Lexicon Pharmaceuticals
NIHR Clinical Research Network: Cancer
Last reviewed: 23 Mar 2020
CRUK internal database number: 11228
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
